What's new? Log in Free sign up

InMode (INMD)

Company Profile

Company profile

Ticker

INMD

Exchange

Website

www.inmodemd.com

CEO

Mr. Moshe Mizrahy

Incorporated

Location

Fiscal year end

Sector

Health Care and Social Assistance > Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Industry (SIC)

Electromedical & Electrotherapeutic Apparatus

MidCap Financial Investment • Varian Medical Systems • CONMED • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Man Ahl Diversified I ...

Former names

LF Capital Acquisition Corp.

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

INMD stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has

Registration of securities for employees

Annual report (foreign)

4 Feb 25

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2

InMode Announces Departures of President of North America, Chief Medical

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares

InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M

InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents

Current report (foreign)

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

BoomerangFX International SRL

BoomerangFX International SRL

Notice of proposed sale of securities

BoomerangFX International SRL

Israel HealthCare Ventures 2 L.P.

SpaMedica International SRL

Beneficial ownership report

Financial summary

Financial statements Chart INMD financial data

Quarter (USD)	Dec 24	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from InMode earnings reports.

Institutional ownership, Q3 2024

INMD institutional ownership history Ownership history

54.8% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	259	263	-1.5%
Opened positions	44	48	-8.3%
Closed positions	48	54	-11.1%
Increased positions	61	82	-25.6%
Reduced positions	104	85	+22.4%

13F shares	Current	Prev Q	Change
Total value	691.38 bn	832.13 bn	-16.9%
Total shares	46.35 mm	52.50 mm	-11.7%
Total puts	1.66 mm	1.66 mm	+0.1%
Total calls	1.81 mm	1.49 mm	+21.9%
Total put/call ratio	0.9	1.1	-17.9%

Largest owners	Shares	Value	Change
BlackRock	6.54 mm	$110.83 bn	NEW
Doma Perpetual Capital Management	2.24 mm	$37.96 bn	+11.3%
Renaissance Technologies	2.22 mm	$37.57 bn	+7.2%
STT State Street	2.04 mm	$34.66 bn	+3.7%
LSV Asset Management	1.71 mm	$28.96 mm	-8.0%
Deerfield Management	1.58 mm	$26.76 bn	+35.3%
Boston Trust Walden	1.41 mm	$23.87 bn	-2.4%
Meitav Dash Investments	1.35 mm	$22.80 bn	-5.2%
MS Morgan Stanley	1.15 mm	$19.54 bn	+12.9%
DDD Partners	1.13 mm	$19.15 bn	-10.8%

Largest transactions	Shares	Bought/sold	Change
BlackRock	6.54 mm	+6.54 mm	NEW
BLK BlackRock	0.00	-6.44 mm	EXIT
FIL	844.84 k	-2.00 mm	-70.3%
Menora Mivtachim	414.44 k	-760.00 k	-64.7%
Acadian Asset Management	450.24 k	-674.65 k	-60.0%
Manufacturers Life Insurance Company, The	27.65 k	-561.97 k	-95.3%
Nuveen Asset Management	279.98 k	-470.92 k	-62.7%
Swedbank AB	348.00 k	-468.00 k	-57.4%
Deerfield Management	1.58 mm	+412.00 k	+35.3%
Migdal Insurance & Financial	0.00	-367.17 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

Barclays Maintains Overweight on InMode, Raises Price Target to $29

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and raises the price target from $26 to $29.

US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?

U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.

Needham Maintains Hold on InModeto Hold

Needham analyst Mike Matson maintains InMode (NASDAQ:INMD) from Hold to Hold.

InMode Board Approves New Share Buyback Program For Up To 10% Of Outstanding Shares, Bringing 15-Month Buybacks To 27% Of Share Capital

InMode Expects 2025 Revenues Of $395M-$405M Compared To Consensus Of $411.452M, With Adjusted EPS Of $1.95-$1.99 Compared To Consensus Of $2.02

Press releases

From Benzinga Pro

InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program

Quarterly GAAP revenues of $97.9 million and full year revenue of $394.8 million Returned $285.4 million of capital to shareholders in full year 2024 Together with new 10% program, represents repurchase of approximately

InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

YOKNEAM, Israel, Feb. 3, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings

InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced

Conference call rescheduled to Tuesday, February 4, 2025, at 8:30 a.m. Eastern Standard Time YOKNEAM, Israel, Jan. 16, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback

InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.